| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.076 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |